IDEAS home Printed from https://ideas.repec.org/p/hal/wpaper/halshs-02563356.html
   My bibliography  Save this paper

Optimal Prevention and Elimination of Infectious Diseases

Author

Listed:
  • Hippolyte d'Albis

    (PSE - Paris School of Economics - UP1 - Université Paris 1 Panthéon-Sorbonne - ENS-PSL - École normale supérieure - Paris - PSL - Université Paris sciences et lettres - EHESS - École des hautes études en sciences sociales - ENPC - École des Ponts ParisTech - CNRS - Centre National de la Recherche Scientifique - INRAE - Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement, PJSE - Paris Jourdan Sciences Economiques - UP1 - Université Paris 1 Panthéon-Sorbonne - ENS-PSL - École normale supérieure - Paris - PSL - Université Paris sciences et lettres - EHESS - École des hautes études en sciences sociales - ENPC - École des Ponts ParisTech - CNRS - Centre National de la Recherche Scientifique - INRAE - Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement)

  • Emmanuelle Augeraud-Véron

    (GREThA - Groupe de Recherche en Economie Théorique et Appliquée - UB - Université de Bordeaux - CNRS - Centre National de la Recherche Scientifique)

Abstract

This article studies the optimal intertemporal allocation of resources devoted to the prevention of deterministic infectious diseases that admit an endemic steady- state. Under general assumptions, the optimal control problem is shown to be formally similar to an optimal growth model with endogenous discounting. The optimal dynamics then depends on the interplay between the epidemiological characteristics of the disease, the labour productivity and the degree of inter- generational equity. Phase diagrams analysis reveal that multiple trajectories, which converge to endemic steady-states with or without prevention or to the elimination of the disease, are feasible. Elimination implies initially a larger prevention than in other trajectories, but after a .nite date, prevention is equal to zero. This .sooner-the-better. strategy is shown to be optimal if the pure discount rate is su¢ ciently low.

Suggested Citation

  • Hippolyte d'Albis & Emmanuelle Augeraud-Véron, 2021. "Optimal Prevention and Elimination of Infectious Diseases," Working Papers halshs-02563356, HAL.
  • Handle: RePEc:hal:wpaper:halshs-02563356
    Note: View the original document on HAL open archive server: https://shs.hal.science/halshs-02563356v2
    as

    Download full text from publisher

    File URL: https://shs.hal.science/halshs-02563356v2/document
    Download Restriction: no
    ---><---

    Other versions of this item:

    References listed on IDEAS

    as
    1. Bell, Clive & Gersbach, Hans, 2013. "Growth and enduring epidemic diseases," Journal of Economic Dynamics and Control, Elsevier, vol. 37(10), pages 2083-2103.
    2. Boucekkine, Raouf & Laffargue, Jean-Pierre, 2010. "On the distributional consequences of epidemics," Journal of Economic Dynamics and Control, Elsevier, vol. 34(2), pages 231-245, February.
    3. Dieter Grass & Jonathan P. Caulkins & Gustav Feichtinger & Gernot Tragler & Doris A. Behrens, 2008. "Optimal Control of Nonlinear Processes," Springer Books, Springer, number 978-3-540-77647-5, September.
    4. Stefano BOSI & David DESMARCHELIER & Manh Hung NGUYEN, 2017. "Biodiversity, infectious diseases and the dilution effect," Working Papers of BETA 2017-23, Bureau d'Economie Théorique et Appliquée, UDS, Strasbourg.
    5. Rowthorn, Robert & Toxvaerd, Flavio, 2012. "The Optimal Control of Infectious Diseases via Prevention and Treatment," CEPR Discussion Papers 8925, C.E.P.R. Discussion Papers.
    6. Martin S Eichenbaum & Sergio Rebelo & Mathias Trabandt, 2021. "The Macroeconomics of Epidemics [Economic activity and the spread of viral diseases: Evidence from high frequency data]," The Review of Financial Studies, Society for Financial Studies, vol. 34(11), pages 5149-5187.
    7. Gersovitz, Mark & Hammer, Jeffrey S., 2005. "Tax/subsidy policies toward vector-borne infectious diseases," Journal of Public Economics, Elsevier, vol. 89(4), pages 647-674, April.
    8. Raouf Boucekkine & Blanca Martínez & J. Ramon Ruiz-Tamarit, 2018. "Optimal Population Growth as an Endogenous Discounting Problem: The Ramsey Case," Lecture Notes in Economics and Mathematical Systems, in: Gustav Feichtinger & Raimund M. Kovacevic & Gernot Tragler (ed.), Control Systems and Mathematical Methods in Economics, pages 321-347, Springer.
    9. Goenka, Aditya & Liu, Lin & Nguyen, Manh-Hung, 2014. "Infectious diseases and economic growth," Journal of Mathematical Economics, Elsevier, vol. 50(C), pages 34-53.
    10. Geoffard, Pierre-Yves & Philipson, Tomas, 1997. "Disease Eradication: Private versus Public Vaccination," American Economic Review, American Economic Association, vol. 87(1), pages 222-230, March.
    11. Korinek, Anton & Bethune, Zachary, 2020. "COVID-19 Infection Externalities: Trading Off Lives vs. Livelihoods," CEPR Discussion Papers 14596, C.E.P.R. Discussion Papers.
    12. Fernando E. Alvarez & David Argente & Francesco Lippi, 2020. "A Simple Planning Problem for COVID-19 Lockdown," NBER Working Papers 26981, National Bureau of Economic Research, Inc.
    13. Barrett, Scott & Hoel, Michael, 2007. "Optimal disease eradication," Environment and Development Economics, Cambridge University Press, vol. 12(5), pages 627-652, October.
    14. Gustav Feichtinger & Vladimir Veliov & Tsvetomir Tsachev, 2004. "Maximum Principle For Age And Duration Structured Systems: A Tool For Optimal Prevention And Treatment Of Hiv," Mathematical Population Studies, Taylor & Francis Journals, vol. 11(1), pages 3-28.
    15. Mark Gersovitz & Jeffrey S. Hammer, 2004. "The Economical Control of Infectious Diseases," Economic Journal, Royal Economic Society, vol. 114(492), pages 1-27, January.
    16. Christopher Avery & William Bossert & Adam Clark & Glenn Ellison & Sara Fisher Ellison, 2020. "Policy Implications of Models of the Spread of Coronavirus: Perspectives and Opportunities for Economists," NBER Working Papers 27007, National Bureau of Economic Research, Inc.
    17. Aditya Goenka & Lin Liu, 2020. "Infectious diseases, human capital and economic growth," Economic Theory, Springer;Society for the Advancement of Economic Theory (SAET), vol. 70(1), pages 1-47, July.
    18. Christopher Avery & William Bossert & Adam Thomas Clark & Glenn Ellison & Sara Ellison, 2020. "Policy Implications of Models of the Spread of Coronavirus: Perspectives and Opportunities for Economists," CESifo Working Paper Series 8293, CESifo.
    19. Théophile Azomahou & Raouf Boucekkine & Bity Diene, 2016. "HIV/AIDS and Development: A Reappraisal of the Productivity and Factor Accumulation Effects," Post-Print halshs-01400506, HAL.
    20. Francis, J. & Kompas, T., 1998. "Uzawa's Transformation and Optimal Control Problems With Variable Rates of Time Preference," Papers 354, Australian National University - Department of Economics.
    21. Théophile T. Azomahou & Raouf Boucekkine & Bity Diene, 2016. "HIV/AIDS and Development: A Reappraisal of the Productivity and Factor Accumulation Effects," American Economic Review, American Economic Association, vol. 106(5), pages 472-477, May.
    22. Michel, Philippe, 1990. "Some Clarifications on the Transversality Condition," Econometrica, Econometric Society, vol. 58(3), pages 705-723, May.
    23. Corrigan, Paul & Glomm, Gerhard & Mendez, Fabio, 2005. "AIDS crisis and growth," Journal of Development Economics, Elsevier, vol. 77(1), pages 107-124, June.
    24. Geoffard, Pierre-Yves & Philipson, Tomas, 1996. "Rational Epidemics and Their Public Control," International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, vol. 37(3), pages 603-624, August.
    25. Michael Kremer, 1996. "Integrating Behavioral Choice into Epidemiological Models of AIDS," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 111(2), pages 549-573.
    26. David Cass, 1965. "Optimum Growth in an Aggregative Model of Capital Accumulation," The Review of Economic Studies, Review of Economic Studies Ltd, vol. 32(3), pages 233-240.
    27. Raouf Boucekkine & Bity Diene & Theophile Azomahou, 2008. "Growth Economics of Epidemics: A Review of the Theory," Mathematical Population Studies, Taylor & Francis Journals, vol. 15(1), pages 1-26.
    28. Raouf Boucekkine & Blanca Martínez & José Ramón Ruiz-Tamarit, 2018. "Optimal Population Growth as an Endogenous Discounting Problem: The Ramsey Case," Post-Print hal-01825912, HAL.
    29. Alwyn Young, 2005. "The Gift of the Dying: The Tragedy of AIDS and the Welfare of Future African Generations," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 120(2), pages 423-466.
    30. Doriana Delfino & Peter J. Simmons, "undated". "Positive and Normative Issues of Economic Growth with Infectious Disease," Discussion Papers 00/48, Department of Economics, University of York.
    31. Michael Kremer, 1996. "Integrating Behavioral Choice into Epidemiological Models of the AIDS Epidemic," NBER Working Papers 5428, National Bureau of Economic Research, Inc.
    32. Momota, Akira & Tabata, Ken & Futagami, Koichi, 2005. "Infectious disease and preventive behavior in an overlapping generations model," Journal of Economic Dynamics and Control, Elsevier, vol. 29(10), pages 1673-1700, October.
    33. Aditya Goenka & Lin Liu, 2012. "Infectious diseases and endogenous fluctuations," Economic Theory, Springer;Society for the Advancement of Economic Theory (SAET), vol. 50(1), pages 125-149, May.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Raouf Boucekkine & Shankha Chakraborty & Aditya Goenka & Lin Liu, 2024. "A Brief Tour of Economic Epidemiology Modelling," LIDAM Discussion Papers IRES 2024002, Université catholique de Louvain, Institut de Recherches Economiques et Sociales (IRES).
    2. Zachariah Sinkala & Vajira Manathunga & Bichaka Fayissa, 2022. "An Epidemic Compartment Model for Economic Policy Directions for Managing Future Pandemic," Papers 2202.05374, arXiv.org.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. David E. Bloom & Michael Kuhn & Klaus Prettner, 2022. "Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses," Journal of Economic Literature, American Economic Association, vol. 60(1), pages 85-131, March.
    2. Luca Gori & Cristiana Mammana & Piero Manfredi & Elisabetta Michetti, 2022. "Economic development with deadly communicable diseases and public prevention," Journal of Public Economic Theory, Association for Public Economic Theory, vol. 24(5), pages 912-943, October.
    3. Goenka, Aditya & Liu, Lin & Nguyen, Manh-Hung, 2021. "SIR economic epidemiological models with disease induced mortality," Journal of Mathematical Economics, Elsevier, vol. 93(C).
    4. Raouf Boucekkine & Shankha Chakraborty & Aditya Goenka & Lin Liu, 2024. "A Brief Tour of Economic Epidemiology Modelling," LIDAM Discussion Papers IRES 2024002, Université catholique de Louvain, Institut de Recherches Economiques et Sociales (IRES).
    5. Aditya Goenka & Lin Liu, 2020. "Infectious diseases, human capital and economic growth," Economic Theory, Springer;Society for the Advancement of Economic Theory (SAET), vol. 70(1), pages 1-47, July.
    6. Goenka, Aditya & Liu, Lin & Nguyen, Manh-Hung, 2014. "Infectious diseases and economic growth," Journal of Mathematical Economics, Elsevier, vol. 50(C), pages 34-53.
    7. Aditya Goenka & Lin Liu & Manh-Hung Nguyen, 2020. "Modeling optimal quarantines under infectious disease related mortality," Working Papers 202025, University of Liverpool, Department of Economics.
    8. Azomahou, Theophile & Soete, Luc & Diene, Bity & Diene, Mbaye, 2012. "Optimal health investment with separable and non-separable preferences," MERIT Working Papers 2012-047, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
    9. Guimarães, Luís, 2021. "Antibody tests: They are more important than we thought," Journal of Mathematical Economics, Elsevier, vol. 93(C).
    10. M. Alper Çenesiz & Luís Guimarães, 2022. "COVID‐19: What if immunity wanes?," Canadian Journal of Economics/Revue canadienne d'économique, John Wiley & Sons, vol. 55(S1), pages 626-664, February.
    11. Martin F. Quaas & Jasper N. Meya & Hanna Schenk & Björn Bos & Moritz A. Drupp & Till Requate, 2020. "The Social Cost of Contacts: Theory and Evidence for the Covid-19 Pandemic in Germany," CESifo Working Paper Series 8347, CESifo.
    12. Bosi, Stefano & Camacho, Carmen & Desmarchelier, David, 2021. "Optimal lockdown in altruistic economies," Journal of Mathematical Economics, Elsevier, vol. 93(C).
    13. Miguel Casares & Paul Gomme & Hashmat Khan, 2022. "COVID‐19 pandemic and economic scenarios for Ontario," Canadian Journal of Economics/Revue canadienne d'économique, John Wiley & Sons, vol. 55(S1), pages 503-539, February.
    14. Peter A.G. van Bergeijk, 2021. "Pandemic Economics," Books, Edward Elgar Publishing, number 20401.
    15. Goenka, Aditya & Liu, Lin & Nguyen, Manh-Hung, 2021. "COVID-19 and a Green Recovery?," Economic Modelling, Elsevier, vol. 104(C).
    16. La Torre, Davide & Liuzzi, Danilo & Marsiglio, Simone, 2021. "Epidemics and macroeconomic outcomes: Social distancing intensity and duration," Journal of Mathematical Economics, Elsevier, vol. 93(C).
    17. Bouveret, Géraldine & Mandel, Antoine, 2021. "Social interactions and the prophylaxis of SI epidemics on networks," Journal of Mathematical Economics, Elsevier, vol. 93(C).
    18. Timo Boppart & Karl Harmenberg & John Hassler & Per Krusell & Jonna Olsson, 2020. "Integrated Epi-Econ Assessment," NBER Working Papers 28282, National Bureau of Economic Research, Inc.
    19. Stefano Bosi & Carmen Camacho & David Desmarchelier, 2020. "Optimal lockdown in altruistic economies," PSE Working Papers halshs-02652165, HAL.
    20. Konstantinos Gkillas & Christoforos Konstantatos & Costas Siriopoulos, 2021. "Uncertainty Due to Infectious Diseases and Stock–Bond Correlation," Econometrics, MDPI, vol. 9(2), pages 1-18, April.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hal:wpaper:halshs-02563356. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: CCSD (email available below). General contact details of provider: https://hal.archives-ouvertes.fr/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.